No Data
No Data
Nanxin Pharmaceutical (688189.SH) announced first-quarter results, net profit of 37.6665 million yuan, a decrease of 69.95%
Nanxin Pharmaceutical (688189.SH) released its report for the first quarter of 2024, achieving operating income of 1.1 during the reporting period...
Private Companies Among Hunan Nucien Pharmaceutical Co., Ltd.'s (SHSE:688189) Largest Stockholders and Were Hit After Last Week's 22% Price Drop
Key Insights Hunan Nucien Pharmaceutical's significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public The top 7 shareholders own 51
Express News | Nanxin Pharmaceutical will reverse losses in 2023, and innovative drugs and specialty generic drugs go hand in hand
Nanxin Pharmaceutical (688189.SH): Has repurchased a total of 1,229,000 company shares
Gelonghui, April 2, 丨 Nanxin Pharmaceutical (688189.SH) announced that as of March 31, 2024, the company had repurchased a total of 1,229,000 shares through the Shanghai Stock Exchange trading system, accounting for 0.4479% of the company's total share capital of 274,400,000 shares. The highest price of the repurchase transaction was 9.24 yuan/share, the lowest price was 5.45 yuan/share, and the total amount of capital paid was RMB 7,997,384.37 (excluding transaction fees such as stamp duty and transaction fees).
Express News | Nanxin Pharmaceutical: Guangzhou Qianyuan plans to reduce its shareholding by no more than 2%
Under the influenza outbreak, Nanxin Pharmaceutical reversed losses in 2023, and the core product market was divided, and it is not ruled out that it will enter collection
① Nanxin Pharmaceutical has begun to cooperate with pharmacy chains such as Sinopharm Group. Currently, the cooperation area mainly revolves around Hunan, where the company is located, and the surrounding area. ② At least 6 domestic manufacturers, including Guilin Southern Pharmaceutical, Yangzijiang Pharmaceutical, and Qilu Pharmaceutical, have been approved for marketing of generic paramivir drugs.
No Data